Clinical Trial Update: An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

View source ↗

Summary

An observational cohort study is being conducted to characterize the effectiveness and safety of Hemgenix in patients with Hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Hemgenix (etranacogene dezaparvovec)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Status: RECRUITING